You've hidden all cards
Q3 2026
EPS
$1.70
est $1.65+3.0%
Revenue
$4.13B
est $4.12B+0.2%
The sixth straight earnings beat lands three days after the $49 billion Kenvue deal closed, putting the debt load at the center of the story. Organic sales fell 1.3%, and management still reaffirmed its 2026 standalone outlook.
Loading…
Q3 2026
EPS
$1.74
est $2.04-14.8%
Revenue
$506M
est $511M-0.9%
Buybacks were the only reason per-share earnings rose at all: the diluted share count dropped to 46.0 million from 55.5 million. Attendance fell on bad weather, calendar shifts and weaker international visitation, and management offered no formal guidance, leaning instead on pass sales and 2027 bookings for Discovery Cove and group business.
Loading…
Q4 2026
EPS
$4.15
est $4.07+2.0%
Revenue
$5.27B
est $5.11B+3.1%
The first full quarter of the slimmed down MedTech company beat on both lines, and management guided fiscal 2027 adjusted EPS to $13.10 to $13.30 against $12.70 last year. Free cash flow jumped 42.5%, the tell that the Life Sciences spin is paying off.
Loading…
Q3 2026
EPS
$0.53
est $0.70-23.8%
Revenue
$4.43B
est $6.12B-27.6%
Earnings came in nearly 24% below consensus, the first real miss in two years, as capital spending jumped 49% to fund the Bell AI Fabric data centre and the Ziply Fiber build. Management still reaffirmed 2026 guidance of 1% to 5% revenue growth and the $1.75 annualized dividend, so the question is whether the AI build pays off before free cash flow thins further.
Loading…
Bill Ackman Says Trump Could Do “The Greatest Real Estate Deal Of All Time” That Would Create “Half A Trillion” Dollars Of Value By Releasing Mortgage Giants From Conservatorship
Bill Ackman says an executive order could free Fannie Mae and Freddie Mac, but Democrats just won Congress, Treasury holds a giant claim on the shares, and Ackman owns a big stake. Who really collects if the deal happens?
Q4 2026
EPS
$3.61
est $3.61-0.0%
Revenue
$3.56B
est $3.34B+6.6%
Management guided fiscal 2027 adjusted EPS to $14.15 to $14.50, growth of 5% to 8%, after cutting capital spending by $1.8 billion and exiting two China coal gasification plants. Revenue came in 6.6% above expectations, with adjusted earnings essentially meeting estimates.
Loading…
Sponsored
Our fiscal 2026 results demonstrate the progress we are making to improve our core industrial gas business, strengthen execution, and allocate capital with discipline. We delivered 12 percent adjusted EPS growth, reduced capital expenditures by $1.8 billion, and expanded our industrial gas project backlog through new business wins.
Menezes is pitching Air Products as a leaner industrial gas operator, with $1.8 billion pulled out of capital spending while earnings still grew. Whether that discipline holds as the project backlog builds is the question for fiscal 2027 guidance.
Rezera Inc.RZRA · Nasdaq
$11–$13 / share
Rezera sets $11-$13 range for $200 million Nasdaq IPO
Rezera just put a number on its Nasdaq debut: $11 to $13 for 16.67 million shares, a roughly $200 million raise with Jefferies, TD Cowen, Cantor and Wedbush PacGrow running the book. Pricing is the next step, and the range is the only shot investors get to gauge the deal before it trades.
Source: SEC filing
BIZD’s 9.69% Expense Ratio Includes Fees Its BDCs Charge Before the Fund Takes Its Cut
BIZD’s 9.69% expense ratio scares off investors before they understand what it actually measures, and that confusion costs them. Knowing where that number comes from changes how you read every yield figure the fund publishes.
Their CPA Will File Them Separately in 2026 So Her Medical Bills Clear the Deduction Floor. His $140,000 Return Will Cost Him $6,355 More in Medicare Surcharges in 2028, Where a Joint Return Would Hav
A retired couple’s CPA spotted a clever way to wipe out her medical bills on their taxes, but the move quietly sets a Medicare tripwire two years out that neither of them saw coming.
Q3 2026
EPS
$7.98
est $7.51+6.3%
Revenue
$73.68B
est $72.45B+1.7%
Cigna lifted its full-year adjusted earnings floor to at least $30.60 a share, its fifth straight quarter topping consensus. Pharmacy Benefit Services pre-tax adjusted income fell on large client contract renewals, and management is spending $3 billion on a multi-year modernization push.
Loading…
The Monthly Check From These 3 Treasury ETFs Moves With Interest Rates. Here’s What Retirees Should Expect
The Fed just moved rates again, and for retirees living off Treasury ETF income, the timing of that monthly check depends entirely on which fund they chose. Three iShares funds sit at very different points on the Treasury curve, and each one tells a different story about what co…